Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)

NCT02894385 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics
Hepatic Insufficiency
Renal Insufficiency

Interventions

DRUG: BAY1841788

Sponsor

Bayer

Collaborators

[object Object]